Menu
GWAS Study

Genomics meets glycomics-the first GWAS study of human N-Glycome identifies HNF1α as a master regulator of plasma protein fucosylation.

Lauc G, Essafi A, Huffman JE et al.

21203500 PubMed ID
GWAS Study Type
2559 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

LG
Lauc G
EA
Essafi A
HJ
Huffman JE
HC
Hayward C
KA
Knežević A
KJ
Kattla JJ
PO
Polašek O
GO
Gornik O
VV
Vitart V
AJ
Abrahams JL
PM
Pučić M
NM
Novokmet M
RI
Redžić I
CS
Campbell S
WS
Wild SH
BF
Borovečki F
WW
Wang W
KI
Kolčić I
ZL
Zgaga L
GU
Gyllensten U
WJ
Wilson JF
WA
Wright AF
HN
Hastie ND
CH
Campbell H
RP
Rudd PM
RI
Rudan I
Chapter II

Abstract

Summary of the research findings

Over half of all proteins are glycosylated, and alterations in glycosylation have been observed in numerous physiological and pathological processes. Attached glycans significantly affect protein function; but, contrary to polypeptides, they are not directly encoded by genes, and the complex processes that regulate their assembly are poorly understood. A novel approach combining genome-wide association and high-throughput glycomics analysis of 2,705 individuals in three population cohorts showed that common variants in the Hepatocyte Nuclear Factor 1α (HNF1α) and fucosyltransferase genes FUT6 and FUT8 influence N-glycan levels in human plasma. We show that HNF1α and its downstream target HNF4α regulate the expression of key fucosyltransferase and fucose biosynthesis genes. Moreover, we show that HNF1α is both necessary and sufficient to drive the expression of these genes in hepatic cells. These results reveal a new role for HNF1α as a master transcriptional regulator of multiple stages in the fucosylation process. This mechanism has implications for the regulation of immunity, embryonic development, and protein folding, as well as for our understanding of the molecular mechanisms underlying cancer, coronary heart disease, and metabolic and inflammatory disorders.

2,559 European ancestry individuals

Chapter III

Study Statistics

Key metrics and study information

2559
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
U.K., Croatia
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.